Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Over the last 12 months, insiders at Hologic, Inc. have bought $0 and sold $8.9M worth of Hologic, Inc. stock.
On average, over the past 5 years, insiders at Hologic, Inc. have bought $0 and sold $22.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 26,000 shares for transaction amount of $1.01M was made by Dockendorff Charles J (director) on 2018‑03‑15.
2024-03-14 | Sale | GARRETT SCOTT T | director | 16,441 0.0069% | $75.50 | $1.24M | +0.14% | |
2024-03-08 | Sale | CRAWFORD SALLY | director | 9,039 0.0038% | $76.40 | $690,607 | -1.93% | |
2024-03-08 | Sale | Dockendorff Charles J | director | 1,465 0.0006% | $76.21 | $111,648 | -1.93% | |
2024-01-29 | Sale | Oberton Karleen Marie | Chief Financial Officer | 14,940 0.0064% | $75.00 | $1.12M | +0.10% | |
2024-01-02 | Sale | Dockendorff Charles J | director | 16,017 0.0067% | $72.00 | $1.15M | +3.62% | |
2023-12-11 | Sale | GARRETT SCOTT T | director | 10,000 0.0042% | $68.71 | $687,116 | +8.50% | |
2023-11-29 | Sale | MACMILLAN STEPHEN P | Chairman, President and CEO | 47,711 0.0198% | $70.41 | $3.36M | +5.42% | |
2023-11-21 | Sale | Mitchell Essex D | Div. President, GYN Surgical | 7,500 0.0031% | $71.85 | $538,890 | +3.01% | |
2023-06-15 | Sale | GARRETT SCOTT T | director | 10,000 0.004% | $79.72 | $797,240 | -8.53% | |
2023-05-05 | Sale | Mitchell Essex D | Div. President, GYN Surgical | 2,390 0.001% | $83.73 | $200,115 | -10.65% | |
2023-02-07 | Sale | COHN BENJAMIN JORDAN | Principal Accounting Officer | 9,128 0.0036% | $85.28 | $778,445 | -11.80% | |
2022-12-14 | Sale | Hellmann Elisabeth A | SVP, Human Resources | 1,649 0.0007% | $76.40 | $125,984 | +3.41% | |
2022-11-30 | Sale | MACMILLAN STEPHEN P | Chairman, President and CEO | 33,500 0.0135% | $75.65 | $2.53M | +3.04% | |
2022-11-15 | Sale | Thornal Kevin R | Group Pres, Global Diagnostics | 12,490 0.0051% | $75.30 | $940,509 | +5.18% | |
2022-11-14 | Sale | Griffin John M. | General Counsel | 26,902 0.011% | $76.12 | $2.05M | +3.97% | |
2022-11-11 | Sale | MACMILLAN STEPHEN P | Chairman, President and CEO | 95,422 0.0385% | $75.74 | $7.23M | +3.37% | |
2022-11-01 | Sale | Oberton Karleen Marie | Chief Financial Officer | 14,545 0.0058% | $72.50 | $1.05M | +5.86% | |
2022-05-17 | Sale | Verstreken Jan | Group President, International | 6,500 0.0026% | $78.80 | $512,168 | -5.24% | |
2022-05-17 | Sale | COHN BENJAMIN JORDAN | Principal Accounting Officer | 3,844 0.0015% | $78.75 | $302,730 | -5.24% | |
2022-05-13 | Sale | COHN BENJAMIN JORDAN | Principal Accounting Officer | 3,842 0.0015% | $75.49 | $290,033 | -1.76% |
MACMILLAN STEPHEN P | Chairman, President and CEO | 1239088 0.5279% | $72.27 | 4 | 7 | +18.31% |
CRAWFORD SALLY | director | 132927 0.054% | $72.27 | 0 | 20 | |
Oberton Karleen Marie | Chief Financial Officer | 103916 0.0443% | $72.27 | 0 | 23 | |
GARRETT SCOTT T | director | 48611 0.02% | $72.27 | 0 | 3 | |
Mitchell Essex D | Div. President, GYN Surgical | 12827 0.0055% | $72.27 | 0 | 2 | |
Dockendorff Charles J | director | 1572 0.0006% | $72.27 | 1 | 2 | +5.07% |
ICAHN CARL C | 28154879 11.9945% | $72.27 | 0 | 1 | ||
MUIR GLENN P | Executive VP and CFO | 815306 0.3473% | $72.27 | 1 | 55 | <0.0001% |
CASCELLA ROBERT | CEO and President | 400655 0.1707% | $72.27 | 1 | 18 | <0.0001% |
CUMMING JOHN W | Chairman | 305975 0.1304% | $72.27 | 1 | 16 | <0.0001% |
Griffin John M. | General Counsel | 168944 0.072% | $72.27 | 0 | 5 | |
STEIN JAY A | Chief Technical Officer | 164608 0.0701% | $72.27 | 0 | 50 | |
SULLIVAN PATRICK J | Executive Chairman | 129874 0.0553% | $72.27 | 0 | 23 | |
Verstreken Jan | Group President, International | 64191 0.0273% | $72.27 | 0 | 1 | |
MCDANIEL C WILLIAM | director | 63660 0.0271% | $72.27 | 1 | 0 | <0.0001% |
Thornal Kevin R | Group Pres, Global Diagnostics | 62368 0.0266% | $72.27 | 0 | 3 | |
Valenti Peter J. III | Division Pres., Breast Health | 59991 0.0256% | $72.27 | 0 | 11 | |
Harding David | SVP, International | 57169 0.0244% | $72.27 | 0 | 4 | |
Mills Roger D. | GSVP & GM Service & Operations | 56960 0.0243% | $72.27 | 0 | 1 | |
SOLTANI PETER | SVP & GM, Women's Health | 56704 0.0242% | $72.27 | 1 | 8 | +23.37% |
LEAMING NANCY | director | 51779 0.0221% | $72.27 | 0 | 12 | |
Daugherty Sean S. | Group President, BSH & Surg. | 49091 0.0209% | $72.27 | 0 | 2 | |
Williamson Steve S | SVP, GYN Surgical | 41721 0.0178% | $72.27 | 0 | 7 | |
Stamoulis Christiana | director | 39392 0.0168% | $72.27 | 0 | 4 | |
WILSON WAYNE | director | 39215 0.0167% | $72.27 | 5 | 10 | <0.0001% |
Doran Howard JR | SVP, Diagnostics Products | 38502 0.0164% | $72.27 | 2 | 2 | +2.9% |
Bebo Allison P | SVP, Human Resources | 35680 0.0152% | $72.27 | 0 | 3 | |
Levy Lawrence M | director | 29437 0.0125% | $72.27 | 0 | 28 | |
Brady David J | SVP, Human Resources | 27749 0.0118% | $72.27 | 0 | 6 | |
ULLIAN ELAINE | director | 23810 0.0101% | $72.27 | 1 | 13 | +28.03% |
Casey Mark J | SVP, CAO, GC & Secretary | 14470 0.0062% | $72.27 | 0 | 10 | |
COHN BENJAMIN JORDAN | Principal Accounting Officer | 14298 0.0061% | $72.27 | 0 | 16 | |
LAVALLEE ROBERT H | SVP, Chief Accounting Officer | 11341 0.0048% | $72.27 | 0 | 16 | |
Wendell Amy McBride | director | 10297 0.0044% | $72.27 | 1 | 0 | +4.92% |
LAVANCE DAVID R JR | director | 9362 0.004% | $72.27 | 0 | 17 | |
Hellmann Elisabeth A | SVP, Human Resources | 8545 0.0036% | $72.27 | 0 | 1 | |
Nawana Namal | director | 6954 0.003% | $72.27 | 1 | 0 | +5.08% |
LEVANGIE DANIEL J | director | 6334 0.0027% | $72.27 | 0 | 3 | |
Hastie Rohan | Group SVP & GM Diagnostics | 1500 0.0006% | $72.27 | 0 | 1 | |
PEKARSKY JOHN R | SVP, Sales & Strategic Account | 1519 0.0006% | $72.27 | 0 | 7 | |
Kingsley Stuart A | President, Surgical Division | 1452 0.0006% | $72.27 | 0 | 1 | |
VON STETTEN ERIC | Vice President | 1254 0.0005% | $72.27 | 0 | 2 | |
Compton Eric B. | COO | 795 0.0003% | $72.27 | 1 | 0 | +33.78% |
JACOBS IRWIN | director | 0 0% | $72.27 | 0 | 6 | |
Fajardo Laurie | director | 0 0% | $72.27 | 0 | 2 | |
PECK WILLIAM A | director | 0 0% | $72.27 | 0 | 1 | |
KERSHAW PETER C | VICE PRESIDENT | 0 0% | $72.27 | 0 | 3 | |
Lerner Arthur G | director | 0 0% | $72.27 | 0 | 3 |
The Vanguard Group | $2.09B | 11.48 | 26.79M | -3.2% | -$69.11M | 0.04 | |
BlackRock | $1.82B | 10.02 | 23.39M | -3.58% | -$67.82M | 0.04 | |
T Rowe Price Investment Management Inc | $1.74B | 9.58 | 22.35M | +1.28% | +$22.05M | 1.07 | |
State Street | $816.57M | 4.49 | 10.47M | -5.67% | -$49.11M | 0.04 | |
T. Rowe Price | $490.93M | 2.7 | 6.3M | +77.68% | +$214.63M | 0.06 | |
Victory Capital Management Inc | $444.27M | 2.44 | 5.7M | +12.73% | +$50.18M | 0.45 | |
Geode Capital Management | $429.75M | 2.37 | 5.53M | -0.97% | -$4.21M | 0.04 | |
Morgan Stanley | $373.46M | 2.05 | 4.79M | +41.21% | +$108.99M | 0.03 | |
Macquarie Group | $320.04M | 1.76 | 4.11M | -3.11% | -$10.27M | 0.26 | |
Ameriprise Financial | $273.33M | 1.5 | 3.51M | -1.06% | -$2.92M | 0.08 | |
Invesco | $260.94M | 1.43 | 3.35M | +37.93% | +$71.76M | 0.06 | |
Renaissance Technologies | $220.2M | 1.21 | 2.82M | -29.67% | -$92.88M | 0.35 | |
Fidelity Investments | $218.45M | 1.2 | 2.8M | +104.94% | +$111.86M | 0.02 | |
Northern Trust | $201.32M | 1.11 | 2.58M | -4.65% | -$9.82M | 0.03 | |
Bank of America | $188.88M | 1.04 | 2.42M | +18.97% | +$30.11M | 0.02 | |
Dimensional Fund Advisors | $171.69M | 0.94 | 2.2M | -11.96% | -$23.33M | 0.05 | |
Legal & General | $171.61M | 0.94 | 2.2M | -7.3% | -$13.52M | 0.04 | |
The Manufacturers Life Insurance Company | $162.55M | 0.89 | 2.09M | -3.63% | -$6.13M | 0.15 | |
Amundi | $152.06M | 0.87 | 2.02M | +11.12% | +$15.22M | 0.06 | |
Td Asset Management Inc | $150.84M | 0.83 | 1.93M | +1.96% | +$2.9M | 0.13 | |
EARNEST Partners | $141.42M | 0.78 | 1.81M | +5.78% | +$7.72M | 0.65 | |
HSBC | $138.37M | 0.76 | 1.78M | +10.66% | +$13.32M | 0.1 | |
Goldman Sachs | $133.82M | 0.74 | 1.72M | +30.6% | +$31.35M | 0.03 | |
Citadel Advisors LLC | $129.72M | 0.71 | 1.66M | -45.23% | -$107.1M | 0.08 | |
Ubs Asset Management Americas Inc | $123.68M | 0.68 | 1.59M | -2.68% | -$3.41M | 0.04 | |
BNY Mellon | $122.91M | 0.68 | 1.58M | -7.76% | -$10.34M | 0.02 | |
DekaBank | $120.13M | 0.67 | 1.56M | -4.67% | -$5.88M | 0.22 | |
Deutsche Bank | $118.96M | 0.65 | 1.53M | +3.5% | +$4.02M | 0.05 | |
Nordea Investment Management Ab | $116.8M | 0.65 | 1.51M | +1.32% | +$1.52M | 0.14 | |
American Century Investments | $116.37M | 0.64 | 1.49M | +6.19% | +$6.79M | 0.07 | |
Charles Schwab | $113.85M | 0.63 | 1.46M | +0.94% | +$1.06M | 0.03 | |
Black Creek Investment Management Inc. | $113.31M | 0.62 | 1.45M | New | +$113.31M | 3.44 | |
Wellington Management Company | $112.72M | 0.62 | 1.45M | -20.98% | -$29.93M | 0.02 | |
SEI Investments Company | $110.9M | 0.61 | 1.42M | +8.8% | +$8.97M | 0.17 | |
Parnassus Investments Ca | $111.03M | 0.61 | 1.42M | -50.81% | -$114.7M | 0.24 | |
CalPERS | $108.35M | 0.6 | 1.39M | -2.29% | -$2.54M | 0.08 | |
Candriam S C A | $106.95M | 0.59 | 1.37M | +2.84% | +$2.95M | 0.69 | |
Congress Asset Management Co Ma | $97.29M | 0.54 | 1.25M | +7.49% | +$6.78M | 0.7 | |
Panagora | $96.63M | 0.53 | 1.24M | +12.01% | +$10.36M | 0.48 | |
Sound Shore Management Inc Ct | $86.42M | 0.48 | 1.11M | +10.98% | +$8.55M | 2.7 | |
JPMorgan Chase | $81.95M | 0.45 | 1.05M | -20.91% | -$21.67M | 0.01 | |
Assenagon Asset Management S.A. | $75.95M | 0.42 | 974,177 | +5.21% | +$3.76M | 0.2 | |
Arrowstreet Capital, Limited Partnership | $72.41M | 0.4 | 928,785 | -31.55% | -$33.37M | 0.07 | |
Citigroup | $71.85M | 0.4 | 921,683 | +50.59% | +$24.14M | 0.06 | |
Retirement Systems of Alabama | $64.49M | 0.35 | 827,171 | +30.74% | +$15.16M | 0.25 | |
GW&K Investment Management | $64.18M | 0.35 | 823,225 | +37.91% | +$17.64M | 0.57 | |
D. E. Shaw & Co. | $63.96M | 0.35 | 820,429 | -48.58% | -$60.42M | 0.09 | |
Allianz Asset Management Gmbh | $61.74M | 0.34 | 791,973 | -5.95% | -$3.9M | 0.11 | |
Prudential Financial | $61.38M | 0.34 | 787,270 | +249.8% | +$43.83M | 0.09 | |
Frontier Capital Management Co | $61.11M | 0.34 | 783,867 | -6.88% | -$4.52M | 0.57 |